Eye Care - CIS

  • CIS
  • Revenue in the Eye Care market amounts to US$148.90m in 2024. The market is expected to grow annually by 2.65% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,256m in 2024).
  • In relation to total population figures, per person revenues of US$0.61 are generated in 2024.

Key regions: Thailand, Philippines, Indonesia, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in CIS is experiencing significant growth and development. Customer preferences for eye care products and services are evolving, and there are several trends driving the market forward.

Additionally, local special circumstances and underlying macroeconomic factors are contributing to the growth of the Eye Care market in CIS. Customer preferences in the Eye Care market in CIS are shifting towards a greater emphasis on preventive care and a desire for high-quality products and services. Consumers are becoming more aware of the importance of maintaining good eye health and are seeking out products that can help them achieve this.

They are also looking for innovative solutions that can address specific eye conditions or concerns. This has led to an increased demand for products such as contact lenses, eye drops, and eye supplements. Additionally, there is a growing interest in advanced eye care services, such as laser eye surgery and cosmetic procedures.

Trends in the market are also driving its development. One major trend is the increasing prevalence of digital devices and screens in everyday life. As people spend more time in front of screens, they are experiencing more eye strain and other related issues.

This has created a demand for products that can help alleviate these symptoms, such as blue light-blocking glasses and eye drops for dry eyes. Another trend is the aging population in CIS countries. As the population ages, the incidence of age-related eye conditions, such as cataracts and macular degeneration, is increasing.

This has led to a greater demand for treatments and surgeries to address these conditions. Local special circumstances in CIS countries also play a role in the development of the Eye Care market. For example, some countries in the region have a high prevalence of certain eye conditions, such as myopia or glaucoma.

This creates a need for specialized products and services to address these conditions. Additionally, there may be cultural factors that influence customer preferences and the types of eye care products and services that are in demand. Underlying macroeconomic factors are also contributing to the growth of the Eye Care market in CIS.

Economic growth in the region has led to an increase in disposable income, allowing consumers to spend more on eye care products and services. Additionally, advancements in technology and healthcare infrastructure have made eye care more accessible and affordable, further driving the market forward. In conclusion, the Eye Care market in CIS is experiencing significant growth and development.

Customer preferences for eye care products and services are shifting towards preventive care and high-quality offerings. Trends such as the prevalence of digital devices and an aging population are driving the market forward. Local special circumstances and underlying macroeconomic factors also play a role in the market's development.

Overall, the Eye Care market in CIS is poised for continued growth in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)